Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Big Lots

BellRing Brands Inc

Investors who are in search of high return investments might be interested in the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt's method) are outperforming the U.S. market.

A Trio of Non-Cyclical Stocks for the Value Investor

ST. LOUIS, Dec. 7, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that Brent Layton has been appointed to Executive Vice President, Markets, Products, International, and Chief Business Development Officer, effective January 1, 2021. Mr. Layton will continue to report...

Centene Appoints Brent Layton to Executive Vice President, Markets, Products, International, and Chief Business Development Officer

ST. LOUIS, Nov. 30, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today provided an update on its upcoming 2021 Financial Guidance and Investor Meeting. In recognition of the increase in COVID-19 cases across the country, including in Missouri and St. Louis County, the company will...

Centene Provides Format Update Of Virtual 2021 Financial Guidance And Investor Meeting On December 18, 2020

ST. LOUIS, Nov. 20, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) will host its 2021 Financial Guidance and Investor Meeting, in a virtual format, on Friday, December 18th, 2020. Michael F. Neidorff, Chairman, President and Chief Executive Officer, and Jeffrey A. Schwaneke,...

Centene Corporation To Host Virtual 2021 Financial Guidance And Investor Meeting On December 18, 2020

Athene Holding Ltd. Class A

Cigna

Alphabet

JPMorgan Chase & Co

Leon Cooperman (Trades, Portfolio), founder and chairman of the Omega Advisors Family Office, disclosed that its top five trades for the third quarter included new holdings in Alphabet Inc. (NASDAQ:GOOG)(NASDAQ:GOOGL) and Athene Holding Ltd. (NYSE:ATH) and sells in JPMorgan Chase & Co. (NYSE:JPM), Centene Corp. (NYSE:CNC) and Cigna Corp. (NYSE:CI).

Leon Cooperman's Top 5 Trades of the 3rd Quarter

Albertsons Companies

Beazer Homes USA

Ingredion

AT&T

iShares MSCI EAFE Value ETF

Vanguard S&P 500 Value ETF

Value investing is one of the best ways investors can play the market. Warren Buffet did it -- what's stopping you?

7 Value Stocks That Could Make You the Next Warren Buffett

Centene's (CNC) Marketplace product - Ambetter undertakes technology improvements for benefiting members and new enrollees.

Centene (CNC) Marketplace Product Undergoes Technology Upgrade

Centene (CNC) inks deal to acquire Apixio for availing enhanced AI technology solutions and digitizing its administrative activities.

Centene (CNC) Acquires Apixio, Boosts Data Analytics Portfolio

Centene Corporation (NYSE: CNC) recently announced it signed a definitive agreement to buy Apixio. These are the details.

Why Centene Is Buying Apixio

ST. LOUIS, Nov. 4, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will participate at two virtual conferences this month. On Tuesday, November 10, at 8:45 a.m. Eastern Standard Time (EST), Centene will participate in a virtual format at the Credit Suisse 29th...

Centene To Participate At Upcoming Conferences

Centene Corporation may not be a household name, but it is a leading provider of government-sponsored health plans. It's weathering the current pandemic well, and has seen continued membership growth.

Centene Corporation: 32% Upside For This Healthcare Insurer

Centene (CNC) could produce exceptional returns because of its solid growth attributes.

Here is Why Growth Investors Should Buy Centene (CNC) Now

Centene Corporation (CNC) CEO Michael Neidorff on Q3 2020 Results - Earnings Call Transcript

Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.

Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues

Centene (CNC) delivered earnings and revenue surprises of 31.25% and 2.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Surpasses Q3 Earnings and Revenue Estimates

Centene, which completed its acquisition WellCare earlier this year to create a national health plan, reported revenue jumped 53% to $29 billion, putting the company on track to eclipse $109 billion in revenue for 2020.

Centene's Enrollment Jumps Thanks To WellCare And Pandemic Enrollment

ST. LOUIS, Oct. 27, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the third quarter ended September 30, 2020, reporting diluted earnings per share (EPS) of $0.97 and Adjusted diluted EPS of $1.26, including the risk corridor, charitable...

Centene Corporation Reports Third Quarter 2020 Results

Centene's (CNC) Q3 results are likely to reflect benefits from growing revenues and improving membership.

Centene (CNC) to Report Q3 Earnings: What's in the Cards?

ATLAS CORP

Franklin Resources

Spectrum Brands Hlds

Teva Pharmaceutical

ViacomCBS

When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

6 Low Price-to-Book Stocks That May Prove to be Solid Bets

Tecnoglass

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Centene Corporation (CNC), Atlas Corp. (ATCO), Spectrum Brands (SPB) and Tecnoglass (TGLS) boast low P/CF ratio.

Give Your Investing Power a Boost With 4 Low P/CF Stocks

Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Centene (CNC) Reports Next Week: What You Should Expect

UnitedHealth Group

CNC vs. UNH: Which Stock Is the Better Value Option?

CNC or UNH: Which Is the Better Value Stock Right Now?

Centene's (CNC) 2021 health plans will not only expand its presence by 30% in the United States but also provide improved health outcomes for its members.

Centene's 2021 Medicare Plans to Strengthen U.S. Footprint

Graphic Packaging Hld

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

3 Low Price-to-Book Stocks to Build Your Portfolio in October

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

News for Centene Stock (CNC)